Great-West Lifeco
$89.91Change from previous close: +1.56%Absolute change: +$1.38
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $80.49B
- Enterprise value
- -$106.81B
- P/E (trailing 12 months)
- 18.6
- Forward P/E
- 14.1
- PEG
- 1.77
- Price/book
- 2.85
- Price/sales
- 2.21
- EV/EBITDA
- -11.0
- EV/revenue
- -2.93
Profitability and growth
- Gross margin
- 47.9%
- Operating margin
- 16.4%
- Net margin
- 12.7%
- ROE
- 14.1%
- ROA
- 0.7%
- ROIC
- 18.4%
- Revenue growth (year over year)
- 5.4%
- Earnings growth (year over year)
- 19.8%
Financial health
- Total cash
- $201.43B
- Total debt
- $8.97B
- Debt/equity
- 0.26
- Current ratio
- 29.2
- Quick ratio
- 26.1
- Piotroski F-Score
- 4.00
Dividends
- Annual dividend per share
- $2.68
- Dividend yield
- 3.0%
- Payout ratio
- 52.9%
- Ex-dividend date
- September 1, 2026
Analysts and estimates
- Average price target
- $94.46
- Median price target
- $95.00
- High price target
- $111.00
- Low price target
- $68.00
- Analysts with a price target
- 13
- Consensus
- Buy
- Forward EPS
- $6.35
- EPS estimate, current year
- $5.73
Shares and trading
- Beta
- 0.67
- Average volume
- 1.14M
- Shares outstanding
- 895.2M
- Float
- 260.06M
- Institutional ownership
- 10.3%
- Insider ownership
- 71.6%
- Short interest (% of float)
- 4.9%
- Short ratio (days)
- 3.95